Company Filing History:
1 out of 4 
1 out of 832,891 Years Active: 2002-2008
Title: Chantal Proulx: Innovator in Hematopoietic Cell Research
Introduction
Chantal Proulx is a notable inventor based in Sainte-Foy, Canada. She has made significant contributions to the field of hematopoietic cell research, particularly in the expansion and differentiation of cord blood cells. With a total of 2 patents, her work has the potential to impact medical treatments and therapies.
Latest Patents
Chantal Proulx's latest patents include a method of expanding and differentiating cord blood cells by hyperthermic incubation. This innovative approach is based on previous evidence suggesting positive effects of fever on in vivo hematopoiesis. The study tested the effect of hyperthermia on the expansion and differentiation of megakaryocytes in ex vivo cultures of cord blood CD34-enriched cells. The results showed that cultures maintained at 39°C produced significantly more total cells, MK progenitors, and total MKs compared to those at 37°C. Additionally, her second patent involves a method of producing human interferon-α using Sendai virus-infected hematopoietic stem cells, which offers a novel approach for large-scale production.
Career Highlights
Throughout her career, Chantal has worked with Hema-Québec, where she has applied her expertise in hematopoietic cell research. Her innovative methods have the potential to enhance the understanding and treatment of various blood-related conditions.
Collaborations
Chantal has collaborated with notable individuals in her field, including Nicolas Dupuis and Réal Lemieux. These partnerships have contributed to her research and the advancement of her patented methods.
Conclusion
Chantal Proulx is a pioneering inventor whose work in hematopoietic cell research is paving the way for new medical advancements. Her innovative patents reflect her commitment to improving health outcomes through scientific research.